A popular drug used for diabetes and weight loss may also help protect the brain. That’s the key message from a new study ...

A real-world study found that semaglutide prescriptions were associated with improvements in weight, blood pressure, and ...

In this cohort study of adults prescribed semaglutide, initiation was associated with reductions in weight and cardiovascular risk ...

The risk for major adverse cardiovascular events decreased with tirzepatide vs. liraglutide and semaglutide in patients with ...

In this cohort study of adults prescribed semaglutide, initiation was associated with reductions in weight and cardiovascular risk factors but increases in health care expenditures, excluding ...

NAION is the second most frequent cause of vision loss due to optic nerve damage, with advanced age and long-standing type 2 ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.

Those taking semaglutide often have other health conditions that can raise the risk of NAION. There’s also a theory that GLP-1 drugs may activate your sympathetic nervous system (your body’s ...

FAT jabs do often sound like a magical quick fix to overeating and demanding hunger pangs.  But the drugs can leave some users feeling seriously unwell and many in hospital. After scouring ...

Once-weekly semaglutide significantly slowed epigenetic aging in adults with HIV-associated lipohypertrophy, as measured by ...